Latest news with #EverywhereVentures
Forbes
20-06-2025
- Business
- Forbes
A Tale Of Two Cities In Venture Capital
Like a desert and an oasis, there is a tale of two cities in venture capital 'It was the best of times, it was the worst of times.' On the heels of Super Venture & Super Return Berlin, and a LP/GP summit in Montreal organized by Inovia, I wanted to reflect on what felt like a panoramic view of the industry, across 1) managers of VC funds 2) startups raising capital and 3) incumbents in the public markets. What struck me most wasn't any one deal or datapoint, but the duality of two starkly different realities. The technology industry today, for startups and venture capital firms alike, is best described as a tale of two cities. In venture capital, the divergence could not be more stark. Research by Pitchbook demonstrated that nine firms collected 50% of all venture funding last year. The top 30 took the vast majority, across a few hundred firms that announced raises. At SuperReturn, partners from megafunds spoke about oversubscribed raises. Meanwhile, emerging managers are scraping to survive and define their edge. As Scott Hartley, co-founder and managing partner of Everywhere Ventures told me: 'For emerging managers differentiation is key, as venture returns heavily skew due to a long tail of large outcomes. While it may seem safer to get on-base at bats, median venture returns barely outpace other asset classes. The reason allocators look at VC is for asymmetric exposure, which means providing capital to yet undiscovered drivers of the future economy.' First-time and even second-time funds have faced arguably one of the hardest fundraising markets in history. Similar research from Pitchbook suggests a risk of certain emerging managers dying off. One panelist summed it up succinctly: 'Consolidation is the new diversification.' The gulf between the haves and have-nots is perhaps even more stark in startups, the companies VCs fund. Asaf Horresh of Vintage explained during his Super Venture keynote: 'if you're AI it's 2021'. Capital is flowing freely into foundation model startups, AI infrastructure plays, and workflow automation layers. Several venture firms have reoriented their entire sourcing around AI, and LPs are watching closely. But for nearly everyone else, Asaf put it perfectly: 'you're in the desert.' Even solid companies are seeing down rounds or resorting to insider-led bridges. The bar has never been higher. While I am nervous about nosebleed valuations and non-Camel strategies- the potential for AI justified. But the capital imbalance is striking. At SuperReturn, AI was on nearly every main stage. As Arpan Punyani, Co-Founder and General Partner at Garuda Ventures told me: 'Like the transistor, cloud, or mobile, AI is a foundational enabling technology. If you're not building an AI company at some level, the bar is just incredibly high to raise venture capital now.' Carta noted that seed deals are growing scarcer, demonstrating the growing scarcity. However, average valuations, pulled up by A.I. startups have increased. The other vector in startups was geography. Today, like it or not, capital is re-concentrating in the old capitals partially because of AI: San Francisco, London, Tel Aviv. Startups in non-central ecosystems are finding it that much harder to raise capital. From side conversations, there's a growing sense that global GPs need to 'earn the right' to go abroad again. The irony (and certainly central to my day job at Fluent Ventures) some of the best startups are being built in emerging ecosystems—with less burn, less competition, and lower valuations. The bifurcation is not limited to venture. In the public markets, the 'Magnificent Seven' (Nvidia, Meta, Apple, et al.) account for the lion's share of returns. Small caps and international equities remain underloved. It's the same pattern: consolidation of value, divergence of experience. In the technology industry, the power law is the rule of the game. But the magnitude of the power law is not. As exits increase, releasing DPI, market sentiment calms, and desire for diversification outside the U.S. grows, I expect much of this to normalize. But this will take time and there will certainly be collateral damage. But, as history tells us, sometimes, the revolution begins in the second city.
Entrepreneur
06-06-2025
- Business
- Entrepreneur
Manila-Based telehealth Startup &you Secures Pre- Seed Funding from International Investors
The company is launching with a focus on some of the most neglected and misunderstood health issues in Southeast Asia. But its broader ambition is to become the region's most seamless and trusted online healthcare platform — a market expected to surpass $22 billion by 2030, growing at a CAGR of over 18%. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media. &you ( a health tech startup founded by entrepreneur Emil Eriksen, has raised an undisclosed amount in pre-seed funding, backed by a strategic group of early investors in a round led by New York-based VC Everywhere Ventures. "Despite a dynamic global trade environment, the macro tailwinds behind Southeast Asia and the Philippines in particular are unquestionable. We believe in rising prosperity, the incredible power of an expanding middle class, and the demand that creates for quality healthcare products. We are excited to be investing in the Philippines for the fifth time," said Scott Hartley, co-founder and managing partner, Everywhere Ventures. The company is launching with a focus on some of the most neglected and misunderstood health issues in Southeast Asia. But its broader ambition is to become the region's most seamless and trusted online healthcare platform — a market expected to surpass $22 billion by 2030, growing at a CAGR of over 18%. Rebuilding Healthcare Starts with Restoring Trust In the Philippines, trust in the healthcare system is in short supply — and for good reason. Ninety percent of people self-medicate, not by choice but out of necessity. Seven in ten rural patients travel hours just to see a specialist. Half of Filipinos can't reach a clinic within 30 minutes, and 50% of families face financial hardship just trying to access basic care. For millions, traditional healthcare is either out of reach, unaffordable, or unreliable. That's the gap &you is stepping into — not just with technology, but with a new model built around clinical credibility, licensed care, and patient trust. Tech at its core — not layered on later While a few players already exist in the space, &you believe the current offerings fall short — especially in markets like the Philippines, where patients are often left with overpriced products, clunky apps, or worse: black-market alternatives. &you offers licensed doctor consultations and FDA-compliant treatments through a streamlined digital platform — no clinic visits required. &you is developing a fully localized end-to-end system — from mobile onboarding and medical intake to prescription and nationwide delivery — built specifically for Southeast Asia's infrastructure and behavior. The platform will use advanced technology to help users assess their health and connect them with licensed local doctors to create personalized treatment plans. "We're addressing unique regional challenges such as disrupted supply chains, user- unfriendly platforms, and a significant trust deficit. Our goal is to make getting help feel as easy and safe as ordering food," said Emil Eriksen, Founder of &you. A Homegrown Model with Global Standards Behind the scenes, &you works only with FDA-compliant partners and fully-licensed doctors, ensuring that all treatments are not only accessible but also safe and fully regulated. The company emphasizes user experience and clinical credibility — not just cheaper medicine. All &you orders are handled through carefully selected partners to ensure a smooth and confidential delivery experience. Early Traction Signals Big Demand Since launching just this April, &you has already seen rapid traction, with thousands of customers in the few month, and expects to scale quickly as awareness grows. The new funding will be used to scale engineering, expand local operations, and prepare for entry into new verticals in the next 12 months. "Healthcare doesn't work here the way it should," Eriksen says. "We're fixing that — one problem, one product, and one person at a time."
